Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults

Clinical trial NCT06798831 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06798831
Sponsor: BioNet-Asia Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pertussis Vaccine

Start date: 2025-02-08
Primary completion: 2025-04-04
Enrollment: 2399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.